Oncology Institute (TOI) Preferred Stock Liabilities (2020 - 2021)
Oncology Institute (TOI) reported Preferred Stock Liabilities of $230.0 million for Q3 2021, up 767.68% on a YoY basis from $26.5 million in Q3 2020, and up 680.44% quarter-over-quarter from $29.5 million in Q2 2021.
Oncology Institute (TOI) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
Oncology Institute has reported Preferred Stock Liabilities for 2 years, with the latest figure at $230.0 million in Q3 2021.
- For the quarter ending Q3 2021, Preferred Stock Liabilities rose 767.68% year-over-year to $230.0 million; the trailing twelve-month figure through Sep 2021 stood at $230.0 million (up 767.68% YoY), and the FY2020 full-year result was $230.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q3 2021 stood at $230.0 million, up from $29.5 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $230.0 million in Q1 2020, with the low at $23.3 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | - |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | - |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | - |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | - |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | - |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | - |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | - |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | - |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | - |
| 10 | Oncology Institute | 535.99 Mn | 505.71 Mn | 139.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 230.00 Mn |
| Jun 30, 2021 | 29.47 Mn |
| Mar 31, 2021 | 23.35 Mn |
| Dec 31, 2020 | 230.00 Mn |
| Sep 30, 2020 | 26.51 Mn |
| Jun 30, 2020 | 205.91 Mn |
| Mar 13, 2020 | 230.00 Mn |